NCT05975905Phase 2Terminated

A Study to Investigate the Safety and Efficacy of KER-012 in Combination With Background Therapy in Adult Participants With Pulmonary Arterial Hypertension (PAH) (TROPOS Study).

Study sponsor: Keros Therapeutics, Inc. · KROS

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2025-03-05Actual
Enrollment · participants113Actual
Source updated2026-07-02Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Recruitment status changed

Before: Completed. After: Terminated.

Check registry source

· 1 field changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Change from Baseline in PVR (Pulmonary Vascular Resistance). After: Measure: Change From Baseline in PVR (Pulmonary Vascular Resistance).

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview